NEW YORK (GenomeWeb) – Finnish in vitro molecular diagnostics manufacturer Mobidiag has completed a €4.0 million ($4.3 million) funding round, the firm announced today. The funding was supported by Finnish investment service company Kansalaisrahoitus Oy.